Prevalence of Gastrointestinal Symptoms in Chinese Community-Dwelling Adults with and Without Diabetes

Overview

Journal Nutrients

Date 2022 Sep 9

PMID 36079764

Authors

Miaomiao Sang

Tongzhi Wu

Xiaoying Zhou

Michael Horowitz

Karen L Jones

Shanhu Qiu

Haijian Guo

Bei Wang

Donglei Wang

Christopher K Rayner

Zilin Sun

Affiliations

Soon will be listed here.

Abstract

Background: Gastrointestinal symptoms have been reported to occur frequently in diabetes, but their prevalence in Chinese community-dwelling individuals with diabetes is unknown. The present study aimed to address this issue and explore the risk factors for gastrointestinal symptoms.

Methods: A total of 1304 community-dwelling participants (214 with diabetes, 360 with prediabetes and 730 with normoglycemia) were surveyed for gastrointestinal symptoms using the Diabetes Bowel Symptom Questionnaire. Logistic regression analyses were applied to identify risk factors for gastrointestinal symptoms.

Results: Of the overall study population, 18.6% reported at least one gastrointestinal symptom, without a significant difference between subjects with normoglycemia (17.7%), prediabetes (19.7%) and diabetes (20.1%). In all three groups, lower gastrointestinal symptoms, particularly diarrhea and constipation, were the most frequent. There was an interaction between age (≥65 years) and diabetes on the prevalence of at least one gastrointestinal symptom ( = 0.01) and of constipation ( = 0.004), with these being most frequent in subjects with diabetes aged ≥ 65 years. After multivariable adjustment, female gender and older age were associated with increased odds of at least one gastrointestinal symptom, specifically lower gastrointestinal symptoms. Older age was also associated with an increase in upper gastrointestinal symptoms.

Conclusions: Gastrointestinal symptoms are common in Chinese community-dwelling adults with and without diabetes. Females, and the elderly with diabetes, are at an increased risk of symptoms.

Citing Articles

Prevalence, risk factors, impact and management of constipation among adults in Urumqi, China: a cross-sectional survey.

Shi L, Shi L, Wei M, Zhang M, Zhang Y, Li J Front Nutr. 2024; 11:1451527.

PMID: 39555186 PMC: 11563834. DOI: 10.3389/fnut.2024.1451527.

Impact of glucagon-like peptide 1 receptor agonist liraglutide and dipeptidyl peptidase-4 inhibitor sitagliptin on bowel cleaning and gastrointestinal symptoms in type 2 diabetes.

Tong Y, Huang J, Chen Y, Tu M, Wang W Front Pharmacol. 2023; 14:1176206.

PMID: 37089939 PMC: 10115949. DOI: 10.3389/fphar.2023.1176206.

References

Yao X, Yang Y, Cui L, Zhao K, Zhang Z, Peng L . Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study. J Gastroenterol Hepatol. 2011; 27(4):760-5. DOI: 10.1111/j.1440-1746.2011.06930.x. View

Sperber A, Bangdiwala S, Drossman D, Ghoshal U, Simren M, Tack J . Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2020; 160(1):99-114.e3. DOI: 10.1053/j.gastro.2020.04.014. View

Du Y, Rayner C, Jones K, Talley N, Horowitz M . Gastrointestinal Symptoms in Diabetes: Prevalence, Assessment, Pathogenesis, and Management. Diabetes Care. 2018; 41(3):627-637. DOI: 10.2337/dc17-1536. View

Quan C, Talley N, Cross S, Jones M, Hammer J, Giles N . Development and validation of the Diabetes Bowel Symptom Questionnaire. Aliment Pharmacol Ther. 2003; 17(9):1179-87. DOI: 10.1046/j.1365-2036.2003.01553.x. View

Delgado-Aros S, Richard Locke 3rd G, Camilleri M, Talley N, Fett S, Zinsmeister A . Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol. 2004; 99(9):1801-6. DOI: 10.1111/j.1572-0241.2004.30887.x. View

Maleki D, Locke 3rd G, Camilleri M, Zinsmeister A, Yawn B, Leibson C . Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000; 160(18):2808-16. DOI: 10.1001/archinte.160.18.2808. View

Park D, Lee O, Shim S, Won Jun D, Lee K, Kim H . The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III. J Neurogastroenterol Motil. 2010; 16(2):186-93. PMC: 2879846. DOI: 10.5056/jnm.2010.16.2.186. View

Huang Y, Zhang H, Zhang M, Li W, Wang J, Hu J . The Association Between Fasting C-peptide and Gastrointestinal Symptoms of Gastroparesis in Type 2 Diabetic Patients. J Neurogastroenterol Motil. 2016; 23(2):254-261. PMC: 5383120. DOI: 10.5056/jnm16091. View

Xiao Q, Fang X, Li X, Fei G . Ethnic differences in genetic polymorphism associated with irritable bowel syndrome. World J Gastroenterol. 2020; 26(17):2049-2063. PMC: 7267697. DOI: 10.3748/wjg.v26.i17.2049. View

10.

Liu Y, Sang M, Yuan Y, Du Z, Li W, Hu H . Novel clusters of newly-diagnosed type 2 diabetes and their association with diabetic retinopathy: a 3-year follow-up study. Acta Diabetol. 2022; 59(6):827-835. DOI: 10.1007/s00592-022-01872-5. View

11.

. Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991; 98(5 Suppl):786-806. View

12.

Kim J, Park H, Ko S, Hong S, Sung I, Shim C . Diabetic factors associated with gastrointestinal symptoms in patients with type 2 diabetes. World J Gastroenterol. 2010; 16(14):1782-7. PMC: 2852829. DOI: 10.3748/wjg.v16.i14.1782. View

13.

Talley N, Stanghellini V, Heading R, Koch K, Malagelada J, Tytgat G . Functional gastroduodenal disorders. Gut. 1999; 45 Suppl 2:II37-42. PMC: 1766695. DOI: 10.1136/gut.45.2008.ii37. View

14.

Feldman M, Schiller L . Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med. 1983; 98(3):378-84. DOI: 10.7326/0003-4819-98-3-378. View

15.

Tseng P, Lee Y, Chiu H, Chen C, Liao W, Tu C . Association of diabetes and HbA1c levels with gastrointestinal manifestations. Diabetes Care. 2012; 35(5):1053-60. PMC: 3329853. DOI: 10.2337/dc11-1596. View

16.

Bytzer P, Talley N, Leemon M, Young L, Jones M, Horowitz M . Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001; 161(16):1989-96. DOI: 10.1001/archinte.161.16.1989. View

17.

Qiu S, Du Z, Li W, Chen J, Wu H, Liu J . Exploration and Validation of the Performance of Hemoglobin A1c in Detecting Diabetes in Community-Dwellers With Hypertension. Ann Lab Med. 2020; 40(6):457-465. PMC: 7295957. DOI: 10.3343/alm.2020.40.6.457. View

18.

Bytzer P, Talley N, Jones M, Horowitz M . Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus. Aliment Pharmacol Ther. 2001; 15(1):137-42. DOI: 10.1046/j.1365-2036.2001.00896.x. View

19.

Khoshbaten M, Madad L, Baladast M, Mohammadi M, Aliasgarzadeh A . Gastrointestinal signs and symptoms among persons with diabetes mellitus. Gastroenterol Hepatol Bed Bench. 2014; 4(4):219-23. PMC: 4017431. View

20.

Brummond N, Richard Locke 3rd G, Choung R, Chang J, Schleck C, Zinsmeister A . Effects of Birth Cohorts on the Irritable Bowel Syndrome Support Early-Life Risk Factors. Dig Dis Sci. 2015; 60(7):2112-8. DOI: 10.1007/s10620-015-3565-4. View